In an interview with Evidence-Based Oncology™ (EBO), Neil Iyengar, MD, associate attending physician, breast medical service, Memorial Sloan Kettering Cancer Center, New York, New York, discussed how population health brings an important lens to both oncology practice and research. Iyengar took part in a panel discussion on the topic at the 11th Annual Patient-Centered Oncology Care® meeting, held November 9-10, 2022, in Nashville, Tennessee.
EBO: Can you elaborate on what it means to bring a population health lens to cancer care?
Iyengar: As an oncologist, when I think about population health,
I think it brings an important lens to how I practice oncology but also the type of research that we do. As an oncologist, we’re very much focused on tumor-directed therapy, so oftentimes [that means] matching very specific treatments to specific lesions, say genetic lesions within the tumor. But it is helpful to zoom out and think about how host metabolism and other biological processes, as well as lifestyle and environment, may also influence both cancer risk and response to cancer treatment.
Because there are so many variables in those sorts of aspects of cancer care, population health is very helpful because we can focus on large populations and pull out observations that we may not get from anecdotal, individual experiences. So, when I say that population health helps inform both my practice and the research from a practice lens, population health can be helpful for implementing cancer care models. And from a research lens, population health can be very helpful for asking or understanding what are the right questions to ask. A lot of the questions with regard to lifestyle modification and cancer risk and outcomes were derived from observations of large study cohorts, and we wouldn’t have a lot of the lifestyle modification interventions that we have nowadays without the initial observations that were derived from population scientists.
EBO: What obesity-related cancers are on the rise, and which populations are most at risk?
Iyengar: There are at least 13 cancers that are related to obesity, and I think that this list is growing as we understand and study more cancers that may be linked to metabolic health. Currently, we define obesity by body mass index [BMI], which is derived from population studies where we use BMI as a tool to understand the general metabolic health of large populations. This is, of course, the weight in kilograms, normalized by the height in meters squared, and this has identified, as I said, at least 13 cancers that are associated with obesity.
We also know that 1 out of 6 male cancer-related deaths and 1 out of 7 female cancer-related deaths are related to obesity, so this is a major public health problem. Another issue is that the rates of obesity are on the rise in younger populations, and the American Cancer Society put out a report a few years ago showing that the incidence of cancer in younger cohorts, and specifically obesity-related cancers, is on the rise.1 So, we anticipate that the burden of obesity-related cancers worldwide is likely to increase in the coming years.
On top of that, we and others are identifying that BMI is not the best tool on the individual level to identify cancers that are related to metabolic health. For example, we’ve published a report showing that, in women with a normal body mass index, if the body fat levels are above 33%, this is associated with a doubling or more of the risk of developing invasive breast cancer. This is alarming to me because, normally, we think about people who have a healthy body mass index as not being at risk for obesity-related diseases, including obesity-related cancers.
There’s now a growing literature demonstrating that metabolic obesity in normal weight individuals is linked to multiple cardiometabolic disorders, as well as a growing list of cancers. This is a major issue, and our interventions need to be matched to identify those individuals [who] are at risk either because of their body mass index or their underlying metabolic health. And the subsequent intervention—be it a lifestyle modification— should also match, whether it is weight loss or body recomposition, by increasing muscle mass and decreasing fat mass. These are the kinds of things that we’re currently studying in clinical trials.
Reference
Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4(3):e137-e147. doi:10.1016/S2468-2667(18)30267-6
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Healing Wounds Through Peer Support
September 16th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
Listen
Interval Breast Cancer Risk High Despite Screening, Highlights Need for Risk-Based Approach
March 27th 2025Interval breast cancer rates have remained consistent over 30 years despite age-based screening, highlighting the need for risk-based screening strategies that account for factors like breast density, hormone replacement therapy, and family cancer history to improve early detection.
Read More